Glenmark gets final nod from USFDA for angina treatment drug
The product is a generic version of Gilead Sciences Inc's Ranexa extended-release tablets in the same strengths.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Pharmaceuticals